￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Rubicatin/rubitin combined with irinotecan: efficacy and safety of dual-drug therapy

2026-02-01 22:25:32

Check Details
How much does it cost for one month to treat pulmonary fibrosis with pirfenidone/asrex?

2026-02-01 22:25:32

Check Details
How effective is canafenib in treating colon cancer? Clinical research and efficacy analysis

2026-02-01 22:25:32

Check Details
Which generation of targeted drugs does sotorasib belong to? Pharmacological mechanisms and therapeutic strategies

2026-02-01 22:25:32

Check Details
Targeted drug sotorasiib vs adagrasiib: Which one is more suitable for patients?

2026-02-01 22:25:32

Check Details
Afatinib price trends in 2025: will it be cheaper in the future?

2026-02-01 22:25:32

Check Details
Introduction and marketing status of dutasteride soft capsules

2026-02-01 22:25:32

Check Details
Interpretation of Elivadoven gene therapy news, therapy principles and application prospects

2026-02-01 22:25:32

Check Details
EPKINLY (icarelatumumab) News Flash: New Cancer Treatment Options Added

2026-02-01 22:25:32

Check Details
What are the precautions for taking datopotomab?

2026-02-01 22:25:32

Check Details
Detailed explanation of the therapeutic effect of kovalizumab

2026-02-01 22:25:32

Check Details
Summary of precautions when using Cassimerson

2026-02-01 22:25:32

Check Details
Category
相关知识